4//SEC Filing
STEPHENSON BRIAN C 4
Accession 0000950170-25-029262
CIK 0001743881other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:36 PM ET
Size
10.2 KB
Accession
0000950170-25-029262
Insider Transaction Report
Form 4
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
- Exercise/Conversion
Common Stock
2025-02-25$17.00/sh+8,500$144,500→ 110,964 total - Sale
Common Stock
2025-02-25$33.18/sh−8,400$278,697→ 102,564 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-25−8,500→ 440,170 totalExercise: $17.00Exp: 2029-06-26→ Common Stock (8,500 underlying) - Sale
Common Stock
2025-02-25$34.18/sh−100$3,418→ 102,464 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.
- [F2]Represents the weighted average sale price of the shares sold from $32.63 to $33.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]The shares subject to this option vested in 48 equal monthly installments from June 26, 2019 to June 26, 2023.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001780030
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:36 PM ET
- Size
- 10.2 KB